> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pharmacy Compounding Advisory Committee Meeting 5/8-9
- URL: https://www.fdaweb.com/pharmacy-compounding-advisory-committee-meeting-5-8-9/
- Published: 2017-04-17T12:00:00.000Z
- Updated: 2026-09-14T22:18:01.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138457

*Federal Register* notice: FDA has announced a 5/8-9 Pharmacy Compounding Advisory Committee meeting. During the meeting, panel members will receive updates on certain issues to follow up on discussions from previous meetings, including quality standards and conditions at certain compounding facilities. In addition, the committee intends to discuss six bulk drug substances nominated for inclusion on the section 503A Bulks List — Nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide disodium reduced, nettle (Urtica dioica) whole plant, ubiquinol, vanadyl sulfate, and artemisinin. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-04-17/pdf/2017-07667.pdf?ref=fdaweb.com).